- Advertisement -spot_img

TAG

Research funding

FDA approves groundbreaking cell-based gene therapies for sickle cell disease

(NNPA)—The U.S. Food and Drug Administration (FDA) has greenlit two revolutionary cell-based gene therapies, Casgevy and Lyfgenia, marking a significant leap forward in treating...

Latest news

- Advertisement -spot_img